Two peptides better than one in targeting diabetes, obesity

Researchers have published results showing that a molecule combining the properties of two endocrine hormones is an effective treatment for adult-onset diabetes. The research included clinical trials with human subjects as well as detailed laboratory studies with rodents and monkeys. The drug candidate targets receptors for two naturally occurring peptide hormones, known as GLP-1 and GIP.

Read more...